FTXH icon

First Trust Nasdaq Pharmaceuticals ETF
FTXH

Overview Fund Activity

26 hedge funds and large institutions have $18.3M invested in First Trust Nasdaq Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.

Holders
26
Holders Change
+6
Holders Change %
+30%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
5
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Truist Financial
1
Truist Financial
North Carolina
$5.29M
2
RJA
2
Raymond James & Associates
Florida
$3.01M
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$1.02M
4
SPIA
4
Steward Partners Investment Advisory
New York
$771K
5
KNW
5
Kesler Norman & Wride
Utah
$661K

Top Sellers

1
DADC
1
D.A. Davidson & Co
Montana
$0
2
AWM
2
AE Wealth Management
Kansas
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DADC
26
D.A. Davidson & Co
Montana
– -$6.33M -239,586 Closed
AWM
27
AE Wealth Management
Kansas
– -$4.21M -159,408 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$652K -24,675 Closed
Citadel Advisors
29
Citadel Advisors
Florida
– -$507K -19,181 Closed
Jane Street
30
Jane Street
New York
– -$397K -15,010 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$2K -88 Closed
1
2